{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T07:01:16Z","timestamp":1790319676986,"version":"4.1.0"},"reference-count":24,"publisher":"Scientific Scholar","content-domain":{"domain":["surgicalneurologyint.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.25259\/sni_775_2026","type":"journal-article","created":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T06:50:27Z","timestamp":1790319027000},"page":"540","update-policy":"https:\/\/doi.org\/10.25259\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Endovascular intra-arterial infusion for cerebral glioblastoma"],"prefix":"10.25259","volume":"17","author":[{"given":"Habiba","family":"Abdullahi","sequence":"first","affiliation":[{"name":"Department of Medicine, Near East University, Lefkosa, Cyprus"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayur","family":"Sharma","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Marshall University, School of Medicine, Huntington, West Virginia, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed M.","family":"Shahrabani","sequence":"additional","affiliation":[{"name":"University of Baghdad, College of Medicine, Baghdad, Iraq"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samer S.","family":"Hoz","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, College of Medicine, University of Cincinnati, Cincinnati, Ohio, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10894","published-online":{"date-parts":[[2026,9,25]]},"reference":[{"key":"10.25259\/SNI_775_2026\/ref-1","doi-asserted-by":"crossref","first-page":"624","DOI":"10.3171\/2010.9.JNS101223","article-title":"Safety and maximum tolerated dose of superselective intraarterial cerebral infusion of bevacizumab after osmotic blood-brain barrier disruption for recurrent malignant glioma. Clinical article","volume":"114","author":"Boockvar","year":"2011","journal-title":"J Neurosurg"},{"key":"10.25259\/SNI_775_2026\/ref-2","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.critrevonc.2010.09.001","article-title":"A comprehensive outlook on intracerebral therapy of malignant gliomas","volume":"80","author":"Buonerba","year":"2011","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.25259\/SNI_775_2026\/ref-3","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s11060-016-2153-6","article-title":"Erratum to: Superselective intraarterial cerebral infusion of cetuximab after osmotic blood\/brain barrier disruption for recurrent malignant glioma: Phase I study","volume":"128","author":"Chakraborty","year":"2016","journal-title":"J Neurooncol"},{"key":"10.25259\/SNI_775_2026\/ref-4","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1136\/neurintsurg-2021-018190","article-title":"Perfusion-guided endovascular super-selective intra-arterial infusion for treatment of malignant brain tumors","volume":"14","author":"Chen","year":"2022","journal-title":"J Neurointerv Surg"},{"key":"10.25259\/SNI_775_2026\/ref-5","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s11060-020-03435-6","article-title":"Super selective intra-arterial cerebral infusion of modern chemotherapeutics after blood-brain barrier disruption: Where are we now, and where we are going","volume":"147","author":"D\u2019Amico","year":"2020","journal-title":"J Neurooncol"},{"key":"10.25259\/SNI_775_2026\/ref-6","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1200\/JCO.2025.43.16_suppl.2049","article-title":"A phase I clinical trial on combined (neo-) adjuvant intravenous plus intracranial administration of ipilimumab and nivolumab in recurrent glioblastoma (NEOGLITIPNI)","volume":"43","author":"Dirven","year":"2025","journal-title":"J Clin Oncol"},{"key":"10.25259\/SNI_775_2026\/ref-7","doi-asserted-by":"crossref","first-page":"S295","DOI":"10.4103\/2152-7806.181987","article-title":"Safety and efficacy of carmustine (BCNU) wafers for metastatic brain tumors","volume":"7","author":"Ene","year":"2016","journal-title":"Surg Neurol Int"},{"key":"10.25259\/SNI_775_2026\/ref-8","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1136\/jnis-2025-024057","article-title":"Safety and efficacy of selective and superselective intra-arterial cerebral infusion with blood-brain barrier disruption for glioma: A systematic review and meta-analysis","volume":"18","author":"Ferreira","year":"2026","journal-title":"J Neurointerv Surg"},{"key":"10.25259\/SNI_775_2026\/ref-9","doi-asserted-by":"crossref","first-page":"115702","DOI":"10.1016\/j.addr.2025.115702","article-title":"In vitro models of the interplay between glioblastoma and blood-brain barrier for stratifying drug efficacy","volume":"227","author":"Ferreira","year":"2025","journal-title":"Adv Drug Deliv Rev"},{"key":"10.25259\/SNI_775_2026\/ref-10","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s11060-014-1504-4","article-title":"Intra-arterial carboplatin as a salvage strategy in the treatment of recurrent glioblastoma multiforme","volume":"119","author":"Fortin","year":"2014","journal-title":"J Neurooncol"},{"key":"10.25259\/SNI_775_2026\/ref-11","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1136\/bjophthalmol-2012-301686","article-title":"Experience of intra-arterial chemosurgery with single agent carboplatin for retinoblastoma","volume":"96","author":"Francis","year":"2012","journal-title":"Br J Ophthalmol"},{"key":"10.25259\/SNI_775_2026\/ref-12","doi-asserted-by":"crossref","first-page":"876","DOI":"10.3171\/jns.1985.63.6.0876","article-title":"The rationale and methodology for intra-arterial chemotherapy with BCNU as treatment for glioblastoma","volume":"63","author":"Hochberg","year":"1985","journal-title":"J Neurosurg"},{"key":"10.25259\/SNI_775_2026\/ref-13","doi-asserted-by":"crossref","first-page":"40","DOI":"10.2176\/nmccrj.2014-0025","article-title":"Double-edged sword in the placement of carmustine (BCNU) wafers along the eloquent area: A case report","volume":"2","author":"Kuramitsu","year":"2015","journal-title":"NMC Case Rep J"},{"key":"10.25259\/SNI_775_2026\/ref-14","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1200\/JCO.2017.75.8219","article-title":"Phase I study of DNX-2401 (Delta-24-RGD) oncolytic adenovirus: Replication and immunotherapeutic effects in recurrent malignant glioma","volume":"36","author":"Lang","year":"2018","journal-title":"J Clin Oncol"},{"key":"10.25259\/SNI_775_2026\/ref-15","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1200\/JCO.21.02036","article-title":"Therapy for diffuse astrocytic and oligodendroglial tumors in adults: ASCO-SNO guideline","volume":"40","author":"Mohile","year":"2022","journal-title":"J Clin Oncol"},{"key":"10.25259\/SNI_775_2026\/ref-16","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.6004\/jnccn.2020.0052","article-title":"Central nervous system cancers, version 3.2020 NCCN clinical practice guidelines in oncology","volume":"18","author":"Nabors","year":"2020","journal-title":"J Natl Compr Cancer Netw"},{"key":"10.25259\/SNI_775_2026\/ref-17","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1093\/neuonc\/nov126","article-title":"Long-term results of carmustine wafer implantation for newly diagnosed glioblastomas: A controlled propensity-matched analysis of a French multicenter cohort","volume":"17","author":"Pallud","year":"2015","journal-title":"Neuro Oncol"},{"key":"10.25259\/SNI_775_2026\/ref-18","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s11060-021-03851-2","article-title":"Repeated superselective intraarterial bevacizumab after blood brain barrier disruption for newly diagnosed glioblastoma: A phase I\/II clinical trial","volume":"155","author":"Patel","year":"2021","journal-title":"J Neurooncol"},{"key":"10.25259\/SNI_775_2026\/ref-19","doi-asserted-by":"crossref","first-page":"950167","DOI":"10.3389\/fonc.2022.950167","article-title":"A systematic review on intra-arterial cerebral infusions of chemotherapeutics in the treatment of glioblastoma multiforme: The state-of-the-art","volume":"12","author":"Pinkiewicz","year":"2022","journal-title":"Front Oncol"},{"key":"10.25259\/SNI_775_2026\/ref-20","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s11060-024-04582-w","article-title":"Intrathecal chemotherapy for leptomeningeal disease in high-grade gliomas: A systematic review","volume":"167","author":"Singh","year":"2024","journal-title":"J Neurooncol"},{"key":"10.25259\/SNI_775_2026\/ref-21","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.jinf.2013.12.002","article-title":"Ommaya reservoir-related infections: Clinical manifestations and treatment outcomes","volume":"68","author":"Szvalb","year":"2014","journal-title":"J Infect"},{"key":"10.25259\/SNI_775_2026\/ref-22","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1007\/s00701-026-06796-5","article-title":"Preoperative embolization of feeding arteries in glioblastoma: Technical strategies and clinical utility","volume":"168","author":"Uchida","year":"2026","journal-title":"Acta Neurochir (Wien)"},{"key":"10.25259\/SNI_775_2026\/ref-23","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/s41582-022-00621-0","article-title":"Advances in local therapy for glioblastoma-taking the fight to the tumour","volume":"18","author":"Van Solinge","year":"2022","journal-title":"Nat Rev Neurol"},{"key":"10.25259\/SNI_775_2026\/ref-24","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1097\/00000421-200202000-00013","article-title":"Intratumoral doxorubicin in patients with malignant brain gliomas","volume":"25","author":"Voulgaris","year":"2002","journal-title":"Am J Clin Oncol"}],"container-title":["Surgical Neurology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/surgicalneurologyint.com\/endovascular-intra-arterial-infusion-for-cerebral-glioblastoma\/","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/surgicalneurologyint.com\/surgicalint-articles\/endovascular-intra-arterial-infusion-for-cerebral-glioblastoma\/","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T06:50:30Z","timestamp":1790319030000},"score":1,"resource":{"primary":{"URL":"http:\/\/surgicalneurologyint.com\/surgicalint-articles\/endovascular-intra-arterial-infusion-for-cerebral-glioblastoma\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,25]]},"references-count":24,"alternative-id":["10.25259\/SNI_775_2026"],"URL":"https:\/\/doi.org\/10.25259\/sni_775_2026","relation":{},"ISSN":["2152-7806","2229-5097"],"issn-type":[{"value":"2152-7806","type":"electronic"},{"value":"2229-5097","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9,25]]},"article-number":"540"}}